Cita APA

Loo, C., Glozier, N., Barton, D., Baune, B., Mills, N., Fitzgerald, P., . . . Rodgers, A. (2023). Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): Randomised double-blind active-controlled trial.

Citación estilo Chicago

Loo, C., et al. Efficacy and Safety of a 4-week Course of Repeated Subcutaneous Ketamine Injections for Treatment-resistant Depression (KADS Study): Randomised Double-blind Active-controlled Trial. 2023.

Cita MLA

Loo, C., et al. Efficacy and Safety of a 4-week Course of Repeated Subcutaneous Ketamine Injections for Treatment-resistant Depression (KADS Study): Randomised Double-blind Active-controlled Trial. 2023.